Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Bioinformatics Prioritization of Snps Perturbing Microrna Regulation of Hematological Malignancy-Implicated Genes Publisher Pubmed



Ghaedi H1 ; Bastami M1 ; Zareabdollahi D1 ; Alipoor B2 ; Movafagh A1 ; Mirfakhraie R1 ; Omrani MD1 ; Masotti A3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Genetics Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Clinical Biochemistry Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Bambino Gesu Children's Hospital-IRCCS, Gene Expression - Microarrays Laboratory, V.le San Paolo 15, Rome, 00146, Italy

Source: Genomics Published:2015


Abstract

The contribution of microRNAs (miRNAs) to cancer has been extensively investigated and it became obvious that a strict regulation of miRNA-mRNA regulatory network is crucial for safeguarding cell health. Apart from the direct impact of miRNA dysregulation in cancer pathogenesis, genetic variations in miRNAs are likely to disrupt miRNA-target interaction. Indeed, many evidences suggested that SNPs within miRNA regulome are associated with the development of different hematological malignancies. However, a full catalog of SNPs within miRNAs target sites of genes relevant to hematopoiesis and hematological malignancies is still lacking. Accordingly, we aimed to systematically identify and characterize such SNPs and provide a prioritized list of most potentially disrupting SNPs. Although in the present study we did not address the functional significance of these potential disturbing variants, we believe that our compiled results will be valuable for researchers interested in determining the role of target-SNPs in the development of hematological malignancies. © 2015 Elsevier Inc.
Other Related Docs
12. The Role of Dna Methylation in Cancer, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
23. Non-Coding Rnas and Glioma: Focus on Cancer Stem Cells, Molecular Therapy Oncolytics (2022)